Therapeutic Effect of Manuka Honey Oral Rinse in Periodontitis Patients Undergoing Hemodialysis
NCT06726876 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2025-12-31
Summary
Chronic Kidney Disease (CKD) has a strong association with chronic periodontitis, an oral disease causing tooth loss linked to inflammation and malnutrition. While periodontitis affects 12.7% of the general population, its prevalence can rise to 39% in certain racial groups, and a dose-response relationship exists with CKD. End Stage Renal Disease (ESRD) patients show a prevalence of periodontitis ranging from 29% to 85.6%. Uremia, immunosuppression, and vitamin D deficiency are suggested factors in the etiology of periodontitis in CKD patients, with uremic toxins potentially altering the oral ecosystem.
Periodontitis involves bacterial biofilm and Gram-negative anaerobes as primary etiological factors. The main treatment goal is to reduce periodontal pathogens and control inflammation, with non-surgical periodontal therapy (NSPT) being the standard. Although various adjuncts like antibiotics and antiseptics are suggested, recent guidelines only recommend certain locally administered agents and systemic antibiotics for specific groups due to increasing bacterial resistance.
Alternative treatments like honey have gained interest, particularly Manuka honey, known for its antibacterial properties against antibiotic-resistant bacteria. This honey's effectiveness is due to its high sugar concentration, low pH, and formation of hydrogen peroxide. Manuka honey's unique component, methylglyoxal (MGO), is a potent bactericide, virucide, and fungicide, linked to its Non-Peroxide Activity (NPA) and Unique Manuka Factor (UMF) rating. MGO also has immunomodulatory effects beneficial for wound healing and tissue regeneration.
Previous studies show Manuka honey as a promising adjunct in NSPT, improving outcomes significantly without adverse effects. Ongoing research aims to evaluate its effects in ESRD patients on hemodialysis, focusing on clinical attachment levels, other periodontal parameters, and FGF 21 levels in gingival crevicular fluid.
Conditions
- Periodontitis
- Hemodialysis
Interventions
- DIETARY_SUPPLEMENT
-
Manuka honey oral rinse.
Name: Manuka Honey Oral Rinse Description: Dosage: Patients will use 20 ml of Manuka honey diluted in 100 ml of purified water. Administration: Oral rinse, performed 3 times per day. Instructions: Patients are instructed to rinse their mouths with the solution for a specified duration and avoid swallowing it. Unique Elements: Active Ingredient: Manuka honey, known for its unique antibacterial properties due to high levels of methylglyoxal (MGO). Mechanism of Action: MGO and Non-Peroxide Activity (NPA) contribute to antibacterial potency, effective against antibiotic-resistant bacteria, and potential immunomodulatory effects that aid wound healing and tissue regeneration. Additional Procedures: Scaling and root debridement, along with the local application of 0.5 ml non-diluted Thyme honey on sites with Probing Pocket Depth (PPD) ≥ 5 mm. Supplementary Care: Patients receive motivation and detailed oral hygiene instructions (proper tooth brushing technique, flossing, use of inte
- DRUG
-
Normal saline rinses.
Dosage: Patients will use 20 ml of normal saline. Administration: Oral rinse, performed 3 times per day. Instructions: Patients are instructed to rinse their mouths with the saline solution for a specified duration and avoid swallowing it. Unique Elements: Control Comparison: Provides a placebo comparison to evaluate the efficacy of the Manuka honey intervention. Additional Procedures: Scaling and root debridement, along with the local application of 0.5 ml non-diluted Thyme honey on sites with Probing Pocket Depth (PPD) ≥ 5 mm.
Sponsors & Collaborators
-
Ain Shams University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-10-01
- Primary Completion
- 2025-12-30
- Completion
- 2025-12-30
Countries
- Egypt
Study Locations
More Related Trials
-
Effect on Teeth and Gum Cleaning in Patients With Gum and Kidney Disease
NCT02901743 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Periodontal Disease Treatment in Patients With Kidney Disease
NCT03648723 ·Status: COMPLETED
-
Manuka Honey as an Adjunct to Non-surgical Periodontal Therapy: Clinical Study
NCT05631600 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
HA35 Treatment the Gingival Discomfort as Well as Gingival Redness and Bleeding of Patients With Periodontitis
NCT05765513 ·Status: COMPLETED ·Phase: NA
-
Non-surgical Periodontal Therapy and Kidney Outcomes in Type 2 Diabetes Mellitus
NCT07256613 ·Status: RECRUITING ·Phase: NA
-
Evaluation of 2%Bromelain Gel With 0.2%CHX Gel as Subgingival LDD Following SRP in Stage II/III and Grade B Periodontitis -A RCT
NCT06505759 ·Status: RECRUITING ·Phase: PHASE1
-
Clinical Efficacy of 1% Metformin and Alendronate Gel in Adjunct to Fibrin in Chronic Periodontitis
NCT06856369 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Adjunct Use of Diode Laser Therapy and Omega 3 Gel in Local Drug Delivery Approach on The Treatment of Localized Aggressive Periodontitis
NCT07056257 ·Status: COMPLETED ·Phase: NA
-
Metformin Versus Chlorhexidine Gel as Adjuncts to Scaling and Root Planing in Stage II Grade B Periodontitis
NCT07215156 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effect of Adjunctive Use of Vitamin B3 and B9 on Myeloperoxidase Level in the GCF of Patients With Stage I and II Periodontitis
NCT05435378 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Treatment for Periodontal Disease in Dialysis Patients
NCT00937976 ·Status: COMPLETED ·Phase: NA
-
Omega-3 and Aspirin in Periodontal Regeneration
NCT01113528 ·Status: COMPLETED ·Phase: PHASE2
-
Home Use of Dual-light Photodynamic Therapy for Chronic Periodontitis
NCT05425784 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Turmeric in Gingival Massaging and Adjunct to Scaling and Root Planing in Chronic Periodontitis Patient
NCT02890771 ·Status: COMPLETED ·Phase: NA
-
The Effect Of Glycemic Control On Malondialdehyde, Glutathione Peroxidase, Glutathione And Paraoxonase
NCT01467674 ·Status: COMPLETED
-
Hydroxylated Polymethoxy Flavones Solid Dispersion in Treatment of Periodontitis
NCT05546788 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Advanced Oxidation Protein Product and Monocyte Chemoattractant Protein-1 in Periodontal Disease
NCT02848378 ·Status: COMPLETED
-
Effect of Non-surgical Periodontal Treatment and C-reactive Protein Levels in Hemodialysis Patients
NCT04262011 ·Status: UNKNOWN ·Phase: NA
-
Does Hyaluronic Acid Affect Periodontal Treatment?
NCT03754010 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness of Enoxolone on Oral Conditions of Patients With Periodontal Surgery
NCT05987722 ·Status: COMPLETED ·Phase: NA
-
Injectable Platelet Rich Fibrin With Non Surgical Periodontal Therapy
NCT04070729 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Injectable Platelet-rich Fibrin Versus Platelet-Rich Plasma As Adjunctive to Scaling and Root Planning in Non-surgical Periodontal Therapy of Periodontitis Patients
NCT06685393 ·Status: COMPLETED ·Phase: NA
-
Glucosamine Sulphate Versus Ginger in Non-Surgical Periodontal Therapy
NCT06200415 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Locally Dilvered Ciprofloxacine Loaded Injectable Platelet-rich Fibrin as an Adjunct to Non-surgical Periodontal Therapy on the Gingival Crevicular Level of Interleukin 6
NCT06968286 ·Status: COMPLETED ·Phase: NA
-
Association of Apical Periodontitis With Chronic Kidney Disease
NCT05818657 ·Status: COMPLETED